Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-24-001668
Filing Date
2024-08-01
Accepted
2024-08-01 17:25:45
Documents
1
Period of Report
2024-07-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form412227017_08012024.html 4  
1 OWNERSHIP DOCUMENT form412227017_08012024.xml 4 4677
  Complete submission text file 0000921895-24-001668.txt   6202
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Issuer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 30B, TOWER 200 THE TOWERS WINSTON CHURCHILL SAN FRANCISCO PAITILLA PANAMA CITY R1 07196
Business Address
Lazar David E. (Reporting) CIK: 0001932843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37367 | Film No.: 241168012